No comorbidities |
|
151(38.2) |
|
|
15 (3.8) |
|
166 (42.1) |
One or more comorbidities |
|
189(47.8) |
|
|
40 (10) |
|
229 (57.9) |
Age Distributions, years |
18–23 |
24–29 |
30–35 |
18–23 |
24–29 |
30–35 |
Group Sums |
Total Number of Patients (%) |
40 (11.8) |
93 (27.4) |
207 (60.9) |
3 (5.5) |
19 (34.5) |
33 (60.0) |
395 |
No comorbidities |
12 (3.0) |
49 (12.4) |
90 (22.8) |
1 (0.3) |
7 (1.8) |
7 (1.8) |
166 |
Patients with |
|
|
|
|
|
|
|
Asthma |
8 (2.0) |
16 (4.1) |
31 (7.8) |
|
3 (0.8) |
5 (1.3) |
63 |
Obstructive sleep apnea |
|
4 (1) |
11 (2.8) |
|
2 (0.5) |
2 (0.5) |
10 |
Other chronic pulmonary diagnosis |
|
1 (0.3) |
2 (0.5) |
|
|
1 (0.3) |
4 |
Hypertension |
2 (0.5) |
4 (1) |
24 (6.1) |
|
5 (1.3) |
9 (2.3) |
44 |
Diabetes mellitus |
|
|
|
|
|
|
68 |
Type I diabetes mellitus |
1 (0.3) |
5 (1.3) |
2 (0.5) |
1 (0.3) |
7 (1.8) |
11 (2.8) |
|
Type II diabetes mellitus |
4 (1) |
7 (1.8) |
24 (6.1) |
|
|
|
|
Gestational diabetes mellitus in pregnancy |
|
|
5 (1.3) |
|
|
|
|
Prediabetes |
|
|
3 (0.8) |
|
|
|
|
Renal diagnoses |
|
|
|
|
|
|
19 |
Nephrotic syndrome |
|
|
1 (0.3) |
|
|
|
|
Chronic kidney disease |
|
|
1 (0.3) |
|
|
|
|
Chronic kidney disease, stage 4 |
|
|
1 (0.3) |
|
|
|
|
Chronic kidney disease, stage 5 |
|
|
1 (0.3) |
|
|
|
|
End stage renal disease |
|
2 (0.5) |
7 (1.8) |
|
1 (0.3) |
2 (0.5) |
|
Chronic kidney disease, unspecified |
|
|
|
|
1 (0.3) |
1 (0.3) |
|
Neuromuscular dysfunction of bladder |
|
|
|
|
1 (0.3) |
|
|
Cardiac diagnoses |
|
|
|
|
|
|
17 |
Atherosclerotic heart disease |
|
|
2 (0.5) |
|
|
|
|
Acute and subacute infective endocarditis |
|
|
|
|
1 (0.3) |
|
Right bundle-branch block |
|
|
1 (0.3) |
|
|
|
|
Pre-excitation syndrome |
|
|
|
|
|
1 (0.3) |
|
Atrial fibrillation |
|
|
|
|
|
1 (0.3) |
|
Diastolic (congestive) heart failure |
|
|
2 (0.5) |
|
|
|
|
Heart Failure |
|
1 (0.3) |
|
|
|
1 (0.3) |
|
Cardiomegaly |
|
|
|
|
|
1 (0.3) |
|
Cardiac murmur |
1 (0.3) |
|
1 (0.3) |
|
|
|
|
Ebstein's anomaly |
|
|
1 (0.3) |
|
|
|
|
Congenital insufficiency of aortic valve |
1 (0.3) |
1 (0.3) |
|
|
|
|
Chronic combined systolic (congestive) and diastolic (congestive) heart failure |
|
|
|
|
1 (0.3) |
|
Tachycardia |
|
1 (0.3) |
|
|
|
|
|
Neurologic diagnoses |
1 (0.3) |
1 (0.3) |
8 (2) |
1 (0.3) |
1 (0.3) |
1 (0.3) |
13 |
Endocrine |
2 (0.5) |
2 (0.5) |
5 (1.3) |
|
1 (0.3) |
2 (0.5) |
12 |
Immunosuppression |
1 (0.3) |
1 (0.3) |
6 (1.5) |
1 (0.3) |
|
|
9 |
Malignancy |
1 (0.3) |
1 (0.3) |
3 (0.8) |
|
|
|
5 |
Autoimmune diagnoses |
|
1 (0.3) |
4 (1) |
|
|
|
|
Mucocutaneous lymph node syndrome [Kawasaki] |
1 (0.3) |
|
|
|
|
|
|
Pre-eclampsia |
|
1 (0.3) |
|
|
|
|
|